Tyrosine phosphorylation and activation of Janus kinase 1 and STAT3 by sublytic C5b-9 complement complex in aortic endothelial cells

Immunopharmacology

Volumn 42, Issue 1-3, 1999, Pages 187-193

  Niculescu, Florin ^a   Soane, Lucian ^a   Badea, Tudor ^a   Shin, Moon ^a   Rus, Horea ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Extracellular signal regulated kinases (ERK); Human aortic endothelial cells; Janus kinase (JAK); Signal transducers and activators of transcription (STAT); Terminal complement complexes

Indexed keywords

COMPLEMENT COMPONENT C5B; COMPLEMENT COMPONENT C9; GUANINE NUCLEOTIDE BINDING PROTEIN; PERTUSSIS TOXIN; PROTEIN KINASE; RAF PROTEIN; STAT3 PROTEIN;

AORTA; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME ACTIVATION; GENE ACTIVATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM;

EID: 0033066412     PISSN: 01623109     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0162-3109(99)00014-4     Document Type: Conference Paper

References (24)

1. Ali M.S., Sayeski P.P., Dirksen L.B., Hayzer D.J., Marrero M.B., Bernstein K.E. Dependence on the motif YIPP for the physical association of Jak2 kinase with the intracellular carboxyl tail of the angiotensin II AT1 receptor. J. Biol. Chem. 272:1997;23382-23388.
2. Carney D.F., Lang T.J., Shin M.L. Multiple signal messengers generated by complement complexes and their role in terminal complement complex elimination. J. Immunol. 145:1990;623-629.
3. Choudhury G.G., Ghosh-Choudhury N., Abboud H.E. Association and direct activation of signal transducer and activator of transcription1alpha by platelet-derived growth factor receptor. J. Clin. Invest. 101:1998;2751-2760.
4. Christiansen V.J., Sims P.J., Hamilton K.K. Complement C5b-9 increases plasminogen binding and activation on human endothelial cells. Arterioscler. Thromb. Vasc. Biol. 17:1997;164-171.
5. Darnell J.E. Jr. Reflections on STAT3, STAT5, and STAT6 as fat STATs. Proc. Natl. Acad. Sci. USA. 93:1996;6221-6224.
6. Darnell J.E. Jr. STATs and gene regulation. Science. 277:1997;1630-1635.
7. DiScipio R.G., Smith C.A., Muller-Eberhard H.J., Hugli T.E. The activation of human complement component C5 by a fluid phase C5 convertase. J. Biol. Chem. 258:1983;10629-10636.
8. Foreman K.E., Vaporciyan A.A., Bonish B.K., Jones M.L., Johnson K.J., Glovsky M.M., Eddy S.M., Ward P.A. C5a-induced expression of P-selectin in endothelial cells. J. Clin. Invest. 94:1994;1147-1155.
9. Gardner A.M., Lange-Carter C.A., Vaillancourt R.R., Johnson G.L. Measuring activation of kinases in mitogen-activated protein kinase regulatory network. Methods Enzymol. 238:1994;258-270.
10. Ihle J.N., Witthuhn B.A., Quelle F.W., Yamamoto K., Thierfelder W.E., Kreider B., Silvennoinen O. Signalling by the cytokine receptor superfamily: JAKs and STATs. Trends Biochem. Sci. 19:1994;222-227.
11. Kilgore K.S., Shen J.P., Miller B.F., Ward P.A., Warren J.S. Enhancement by the complement membrane attack complex of tumor necrosis factor-alpha-induced endothelial cell expression of E-selectin and ICAM-1. J. Immunol. 155:1995;1434-1441.
12. Kilgore K.S., Schmid E., Shanley T.P., Flory C.M., Maheswari V., Tramontini N.L., Cohen H., Ward P.A., Friedl H.P., Warren J.S. Sublytic concentrations of the membrane attack complex of complement induce endothelial interleukin-8 and monocyte chemoattractant protein-1 through nuclear factor-kappa B activation. Am. J. Pathol. 150:1997;2019-2031.
13. Leaman D.W., Pisharody S., Flickinger T.W., Commane M.A., Schlessinger J., Kerr I.M., Levy D.E., Stark G.R. Roles of JAKs in activation of STATs and stimulation of c-fos gene expression by epidermal growth factor. Mol. Cell. Biol. 16:1996;369-375.
14. Niculescu F., Rus H., Lang T., Shin S.S., Shin M.L. Generation of diacylglycerol and ceramide during homologous complement activation. J. Immunol. 150:1993;214-224.
15. Niculescu F., Rus H., Shin M.L. Receptor-independent activation of guanine nucleotide-binding regulatory proteins by terminal complement complexes. J. Biol. Chem. 269:1994;4417-4423.
16. Niculescu F., Rus H., Van Biessen T., Shin M.L. Activation of Ras and mitogen-activated protein kinase pathway by terminal complement complexes is G protein dependent. J. Immunol. 158:1997;4405-4412.
17. Park O.K., Schaefer T.S., Nathans D. In vitro activation of Stat3 by epidermal growth factor receptor kinase. Proc. Natl. Acad. Sci. USA. 93:1996;13704-13708.
18. Rus H.G., Vlaicu R., Niculescu F. Interleukin-6 and interleukin-8 protein and gene expression in human arterial atherosclerotic wall. Atherosclerosis. 127:1996;263-271.
19. Rus H.G., Niculescu F., Shin M.L. Sublytic complement attack induces cell cycle in oligodendrocyte. S phase induction is dependent on c-jun activation. J. Immunol. 156:1996;4892-4900.
20. Sakastsume M., Stancato L.F., David M., Silvennoinen O., Saharinen P., Pierce J., Larner A.C., Finbloom D.S. Interferon γ activation of Raf-1 is JAK-1 dependent and p21 Ras independent. J. Biol. Chem. 273:1998;3021-3026.
21. Shin, M.L., Rus, H.G., Niculescu, F.I., 1996. Membrane attack by complement: assembly and biology of terminal complement complexes. In: Lee, A.K. (Ed.), Biomembranes, Vol. 4. JAI Press Greenwich Ct., pp. 123-149.
22. Sims P.J., Wiedmer T. Induction of cellular procoagulant activity by the membrane attack complex of complement. Semin. Cell Biol. 6:1995;275-282.
23. Tedesco F., Pausa M., Nardon E., Introna M., Mantovani A., Dobrina A. The cytolytically inactive terminal complement complex activates endothelial cells to express adhesion molecules and tissue factor procoagulant activity. J. Exp. Med. 185:1997;1619-1627.
24. Winston L.A., Hunter T. JAK2, Ras, and Raf are required for activation of extracellular signal-regulated kinase/mitogen-activated protein kinase by growth hormone. J. Biol. Chem. 270:1995;30837-30840.